Jourdan M Cancienne1, Kishan J Patel2, James A Browne1, Brian C Werner1. 1. Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia. 2. Department of Orthopaedic Surgery, Larkin Community Hospital, South Miami, Florida.
Abstract
BACKGROUND: Although the United States is in the midst of a narcotic epidemic, risk factors for use and the impact of perioperative narcotic use on total knee arthroplasty (TKA) outcomes is ill-defined. METHODS: A national database was queried for patients who underwent primary TKA from 2007 to 2015. Patients taking narcotics in the preoperative, and for a prolonged period of time postoperatively, were identified. The risk factors for prolonged narcotic use were analyzed with a regression analysis, in addition to evaluating preoperative and prolonged postoperative use as independent risk factors for short-term and long-term complications. RESULTS: In total, 113,337 patients met inclusion criteria, of which 31,733 patients were prescribed narcotics preoperatively and 35,770 patients were prescribed narcotics more than 3 months postoperatively. There are several independent risk factors for prolonged narcotic use postoperatively, the most significant being the number of narcotic prescriptions prescribed preoperatively. Preoperative narcotic use was independently associated with an increased risk of emergency room visits, readmission, infection, stiffness, and aseptic revision. Prolonged postoperative use was also associated with significantly increased rates of infection, stiffness, and aseptic revision. CONCLUSION: Preoperative and prolonged narcotic use following TKA was associated with an increased risk of short-term and long-term complications following TKA. The liberal use of narcotics in the perioperative period should be considered a modifiable risk factor when considering elective TKA.
BACKGROUND: Although the United States is in the midst of a narcotic epidemic, risk factors for use and the impact of perioperative narcotic use on total knee arthroplasty (TKA) outcomes is ill-defined. METHODS: A national database was queried for patients who underwent primary TKA from 2007 to 2015. Patients taking narcotics in the preoperative, and for a prolonged period of time postoperatively, were identified. The risk factors for prolonged narcotic use were analyzed with a regression analysis, in addition to evaluating preoperative and prolonged postoperative use as independent risk factors for short-term and long-term complications. RESULTS: In total, 113,337 patients met inclusion criteria, of which 31,733 patients were prescribed narcotics preoperatively and 35,770 patients were prescribed narcotics more than 3 months postoperatively. There are several independent risk factors for prolonged narcotic use postoperatively, the most significant being the number of narcotic prescriptions prescribed preoperatively. Preoperative narcotic use was independently associated with an increased risk of emergency room visits, readmission, infection, stiffness, and aseptic revision. Prolonged postoperative use was also associated with significantly increased rates of infection, stiffness, and aseptic revision. CONCLUSION: Preoperative and prolonged narcotic use following TKA was associated with an increased risk of short-term and long-term complications following TKA. The liberal use of narcotics in the perioperative period should be considered a modifiable risk factor when considering elective TKA.
Authors: Ruchir N Karmali; Christopher Bush; Sudha R Raman; Cynthia I Campbell; Asheley C Skinner; Andrew W Roberts Journal: Pharmacoepidemiol Drug Saf Date: 2019-12-18 Impact factor: 2.890
Authors: Michael L Kent; Robert W Hurley; Gary M Oderda; Debra B Gordon; Eric Sun; Monty Mythen; Timothy E Miller; Andrew D Shaw; Tong J Gan; Julie K M Thacker; Matthew D McEvoy Journal: Anesth Analg Date: 2019-08 Impact factor: 5.108
Authors: Naheed K Jivraj; Faizal Raghavji; Jennifer Bethell; Duminda N Wijeysundera; Karim S Ladha; Brian T Bateman; Mark D Neuman; Hannah Wunsch Journal: Anesthesiology Date: 2020-06 Impact factor: 7.892
Authors: Afshin A Anoushiravani; Kelvin Y Kim; Mackenzie Roof; Kevin Chen; Casey M O'Connor; Jonathan Vigdorchik; Ran Schwarzkopf Journal: Eur J Orthop Surg Traumatol Date: 2020-01-02
Authors: Michael A McCurdy; Cameran I Burt; Matheus B Schneider; Tina Zhang; Michael J Foster; Ali Aneizi; Mohit N Gilotra; S Ashfaq Hasan; R Frank Henn Iii Journal: J Orthop Date: 2021-05-06
Authors: Gerard Malanga; Faizan Niazi; Vasco Deon Kidd; Edmund Lau; Steven M Kurtz; Kevin L Ong; Andrew L Concoff Journal: Am Health Drug Benefits Date: 2020-09
Authors: Martin H Gregory; Andrew McKinnon; Dustin Stwalley; Kirk J Hippensteel; Edward V Loftus; Matthew A Ciorba; Margaret A Olsen; Parakkal Deepak Journal: J Crohns Colitis Date: 2019-02-01 Impact factor: 9.071